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A b s t r a c t . The effects of thyrotropin releasing hormone (TRH) on the contrac-
tility of electrically stimulated and perfused isolated rat hearts were investigated. 
TRH in the range of 0.1-10 /umol/1 was found to exert a positive inotropic effect on 
cardiac contractility, which however qualitatively differed at lower vs. higher con-
centrations of the hormone: at 1 /miol/1, TRH was found to significantly enhance 
the rate of contraction as well as that of relaxation (by 23.2 ± 3.7 and 27.8 ± 7.7%, 
respectively), which culminated in an increased peak contractile force. However, 
at 10 /umol/1, the positive inotropic effect of TRH (i.e. the increase in peak con-
tractile force) was smaller than at 1 ^anol/1, which apparently was due to both 
a reduced TRH-induced elevation in the rate of contraction (12.4 ± 3.2%J) and a 
TRH-induced decrease in relaxation rate (11.1 ± 8.1%i). Since TRH is expressed in 
the heart, the above findings suggest tha t , in addition to its CNS-mediated car-
diovascular effects. T R H modulates cardiac contractility as an autocrine regulator 
in a concentration-dependent manner, which likely involves more than one TRH 
receptor and associated signaling pathway. 
K e y words: Thyrotropin releasing hormone — Rat heart — Cardiac contractility 
— Positive inotropic effect — Autocrine regulation 
In troduct ion 
Thyrotropin-releasing hormone (TRH) is a tr ipeptide that is best known for its 
involvement in the endocrine regulation of the pituitary-thyroid axis and its se-
cretion by the hypothalamus. On the other hand, it is now well-documented that 
T R H is also present throughout the extrahypothalamic nervous system as well as 
in a number of peripheral tissues (Morley 1979). Accordingly, TRH has been shown 
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to have non-pituitary-related functions, including the regulation of the cardiovas-
cular system. The occurrence of TRH immunoreactivity (Eskay et al. 1983) and 
binding sites (Manaker et al. 1985) have been demonstrated in brain areas that 
are involved in the regulation of the cardiovasculature, and it has been shown that 
its intracerebroventricular injection improves cardiovascular function in both endo-
toxic and hemorrhagic shock (Holaday et al. 1981; Feuerstein et al. 1983; Holaday 
and Faden 1983), as well as it alters arterial pressure and heart rate (Beale et al. 
1977; Delbarre et al. 1977; Koivusalo et al. 1979; Holaday et al. 1983). 
The heart has been recently identified as a new locus for TRH expression 
(Carnell et al. 1992; Lathrop et al. 1994). Furtheimore, it has been also found that 
TRH expression is regulated by different steroid hormones such as glucocoiticoids 
and testosteione (Lathrop et al. 1994). Thus, by using an isolated rat heart model, 
we asked the question whether TRH, as a potential autocrine regulator of the heart, 
manifests any direct influence on cardiac contractility. 
Mater ia l s and M e t h o d s 
Surgical procedures 
Hearts were isolated from Spiague-Dawley rats (260 g on aveiage; Harlan Lab-
oiatoiies. Indianapolis, IN). The animals weie killed by cervical dislocation, in 
accordance with the "Guiding Piinciples in the Care and Use of Animals". After 
niidsteinal thoracotomy, the hearts were excised and perfusion was initiated within 
30 seconds with the means of a polyethylene cathetei inserted into the aorta. Plat-
inum electrodes were attached to the ventricles to control the contractile rate of 
the heart by electrical stimulation (Grass S8800) at an optimal fiequency (240 300 
BPM) which stabilized contractility in time. 
Perfusion procedures 
Each heart was perfused at a constant pressure of 60 cm H T O , at which the flow 
rate through the heart was 3.5 ml /min . resulting in a stable contractility of con-
trol hearts for 5-6 hours. The perfusion fluid (modified Krebs-Henseleit solution) 
contained (in mmol/1) NaCl, 118; N a H C 0 3 , 25; KC1, 4.7; CaCh , 2.5; M g S 0 4 , 1.2; 
KH2PO1, 1.1; and dextrose, 11.0 and was continuously aerated with a mixture of 
95% 0 2 / 5 % C 0 2 to maintain the pH at 7.35 (37°C). A stock solution of TRH 
(Sigma) dissolved in the perfusion medium was delivered with a syringe p u m p into 
the perfusion fluid close to where it entered the heart . The desiied concentrations 
of T R H (as indicated in the text) in the perfusate t ha t reached the heart were 
adjusted by controlling the flow rate of the pump according to the perfusion rate 
set separately. 
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Contractile force measurements 
The apex of the heart was attached, by means of a ligature, to a (S ta tham UC-
3) force transducer that was set up to measure isometric contractile force (F) 
and was interfaced to a chart recorder and an A / D device in a computer. Besides 
continuously monitoring the contractile s ta tus of the heart with the use of the 
chart recorder, digitized data was also collected in segments at a sampling rate 
of 1000 Hz, and analyzed with DaDisp Software. Each collected da ta segment was 
analyzed for maximal force, the rate of force development (+dF/dt) and the rate of 
relaxation (—dF/dt). Due to time-dependent changes in contractile force, the da ta 
presented as percentages of control values were compared to those measured prior 
to the addition of TRH, and are given as means ± S.E. The number of independent 
experiments (i.e. the number of rat hearts) was at least 4. Statistical significance (at 
P < 0.05) was evaluated using analysis of variance followed by Duncan's multiple 
range test. Before every experiment, the hearts were allowed to equilibrate for 30 
min., during which t ime the resting force was set optimally to minimize the baseline 
drift. 
R e s u l t s 
Fig. 1 shows 3-beat long representative segments of force-records before (Trace ^4) 
and 20 mins after (Trace B) the injection of 1 /xinol/1 TRH into the perfusion 
medium. Shortly after the administration of the hoimone (see also Fig. 2), the 
peak force generated by the heart started increasing, and after 15-20 min reached 
a maximum which, on average, was 20—30% highei than the force generated by 
control hearts. This positive inotropic effect observed in the presence of 1 /mrol/1 
F igure 1. Positive inotropic ef-
fect of TRH on isolated rat 
hearts. After a 30 min. equili-
bration period, the heart stimu-
lated at 240 BPM was perfused 
with 1 //mol/l TRH, and the 
force was monitored in segments. 
A; Record before (0 min), B: 
Record 20 min. after TRH was 
introduced. The abscissa applies 
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TRH was appaientlv not associated with airy change in the íegulant j in beating 
of the electucallv paced heait (as it was clearly seen fiom the analysis of long 
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Figure 2. Foice development m isolated lat heaits at vanous time points aftei being 
pi i fused with diifcie nt eoiicciitiations of I RII flu data of peak fence fiom expc nine ills 
siniilai to that shown in 1 ig f is plotted as tlu means ± S T (a\eiaged fiom at least 1 
independent measuie me nts) Ihe asttiisks indicate statistical significance al P < 0 0r) as 
e onipaied to tlu contiol \ ilucs When indicated by two astei lsks the diffeiene e w is also 
significant (at P < 0 05) when eompaied to data points obtained with 1 //mol/1 f Hff 
Fig 2 lllustiates the tempoia l changes m the maximum (peak) fence of iso 
lated heaits m the piesence of \ a n o u s coiicentiations of TRH As seen fiom the 
íesults m the Figuie t lnee piope lties of the TRH-mducod changes on the contiac-
tiht\ of isolated heaits weie noticeable i) the maximal effect of TRH developed 
íathei slow h as it lequneel se\eial minutes to be e rane manifest and was moic 
pionounied at lnghei TRH e once nt iat ions n) the maxnnum foice mcasuied m the 
piesence of 10 //mol/l TRH although still laigei than tha t of the eemtiol was sig 
mficanth leduced as compaied to the foiee measuied m the piesence of 1 /vmol/1 
TRH and m) (as best seen fiom the measmc nients with 0 1 //mol/1 TRH) the 
mciease m maximal foice was t iansient despite the continuous peifusiou of the 
heaits with the hoimone the posi t i \e niotiopie effect aftei leaching a maximum 
seemed to deciease o\e>i time Both the tiansient behavioi of the T R H effect and 
its bell shaped concentiation dependence suggest that TRH exeited a dual effect 
on contiactiliťy which p iobabh i m o h e s the binding of the hoimone to two sets of 
binding sites the sa tmat ion of the íelatrveh lngh-affinit\ sites ( í e at T R H con-
eentiatioiis up to f //mol/1) is likely lesponsible foi the mciease m peak contiactile 
foice while that of the lowei-affmitv site (at 10 //mol/1 T R H ) tends t o íesult m 
the opposite effect (i e a t tenuat ion of the positive motiopic influence) 
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A dual effect of T R H was also observed, when the influences of the hormone on 
the rate of contraction and relaxation were analyzed separately. As shown in Fig. 3, 
at 1 //mol/1 TRH, the rates of contraction (dF/dt) and relaxation (— dF/dt) signif-
icantly increased as compared to the control rates, while at a higher concentration 
(10 /mrol/1), TRH (although still increasing the rate of contraction) significantly 
decreased that of relaxation (by about 10%). 
In summary, the above findings indicate that the TRH-induced increase in peak 
force (positive inotropic effect) is transient (Fig. 2), has a maximum at a particular 
(optimal) TRH concentration (Fig. 2), and is a result of apparently distinct effects 
of the hormone on cardiac contraction and relaxation (Fig. 3). 
Figure 3. The influence of TRH 
on the rate of force development 
(dF/dt) and relaxation (-dF/dt) in 
isolated rat hearts. Data were ob-
tained after 15 min exposure to 1 or 
10 /(mol/1 TRH, and represent the 
aveiage of at least 4 experiments. 
The asterisks show significant differ-





The results repoited herein indicate that TRH exerts a dual effect on caidiac muscle 
contractility, which most likely manifests itself through the binding of TRH to two 
types of TRH binding sites. A relatively slow binding of TRH to a higher-affinity 
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site appears to increase the rate of both contraction and relaxation, while a more 
rapid binding to a lower-affinity site seems to attenuate the rate of relaxation. At 
low concentrations, which appear to be physiologically more relevant (1), TRH is a 
positive inotrope, which likely results from the summation of its accelerating effect 
on both contraction and relaxation. 
The dual effect of TRH on the performance of isolated hearts probably implies 
that TRH, through two separate binding sites, activates two distinct signal trans-
duction pathways in the cardiac muscle cell. In various cell types, TRH has been 
shown to induce cytosolic Ca2 + transients by both the mobilization of the inositol 
1.4,5-trisphosphate (Rebecchi and Gershengorn 1983; MacPhee and Drummond 
1984; Mollard et al. 1990) cascade and the activation of Ca2 + entry into the cyto-
plasm via dihydropyridine-sensitive calcium channels (Enyeart et al. 1985; Wood 
and Schofield 1989). In pituitary cells, TRH has also been shown to increase cy-
tosolic Ca_+ through a yet undetermined signaling pathway (Tashian et al. 1987) 
that might involve the mobilization of cyclic ADP-ribose, a newly discovered acti-
vator of the cardiac Ca~+ release channel (Mészáros et al. 1993). A TRH-induced 
increase in cytosolic Ca2 + through either of the above Ca2 + signaling pathways, 
all of which are documented to be functional in cardiac muscle cells (Brown and 
Jones 1986; Hess et al. 1986; Mikami et al. 1989; Kentish et al. 1990; Mészáros 
et al. 1993), could explain a TRH-induced increase in the rate of contraction, and 
thus an increased peak contractile force. However, a TRH-activated increase in the 
cytoplasmic Ca2 + through either pathways would certainly not be able to account 
for the TRH-induced decrease in the rate of relaxation, which was observed at 
higher TRH concentrations. 
Another important point to note is that, contrary to the TRH-induced rise in 
cytosolic Ca2+ which occurs within seconds in many different types of cells (Tashian 
et al. 1987), both cardiac responses to TRH (i.e. the increase of contraction rate 
and the decrease in relaxation rate) developed rather slowly (when compared, for 
instance, to the adrenaline response, which fully develops within 30 s; not shown). 
Ravindra and Foster (1994) have recently shown that TRH-treatment increases the 
levels of Gq in GH3 pituitary cells, which effect of TRH had a similar time course 
to that we report in this study. Thus, it seems possible that TRH might exert 
its influence in the heart through the regulation of the levels of certain regulatory 
proteins such as G proteins. (In this respect, it is interesting to point out that we 
found a TRH-induced increase in the levels of ADP-ribosylation target proteins, 
most likely G proteins - unpublished observation). 
TRH has been recently found to be expressed in rat hearts (Carnell et al. 
1992; Lathrop et al. 1994). Furthermore, it has been also found that its expression 
in the heart is regulated by different steroid hormones such as glucocorticoids and 
testosterone {Lathrop et al. 1994). Thus, an intriguing possibility appears that the 
widely documented effects of these steroid hormones on cardiac performance might 
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become manifest through a TRH-mediated mechanism. This possibility as well 
as the identification of the TRH-activated signal t ransduction pathways relevant 
to the TRH-mediated alterations in cardiac contractility we describe here seem 
important to address in future studies. 
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